News & Updates
Filter by Specialty:
CLD status does not influence MACE risk associated with ticagrelor vs clopidogrel
Use of ticagrelor compared with clopidogrel contributes to a similar risk of major adverse cardiovascular events (MACE) and a higher risk of major bleeding in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), reveals a study.
CLD status does not influence MACE risk associated with ticagrelor vs clopidogrel
01 Aug 2024
Medication adherence prevents hospitalization among hypertensive, diabetic older adults
Older adults with diabetes and hypertension who regularly take their medications tend to have fewer hospitalizations or visits to the emergency room (ER), reports a study.
Medication adherence prevents hospitalization among hypertensive, diabetic older adults
01 Aug 2024
Prior MI or stroke may predict diuretic use for HTN management
A prespecified secondary analysis of the Diuretic Comparison Project (DCP) shows that when deciding between chlorthalidone (CTD) and hydrochlorothiazide (HCTZ) for the management of hypertension (HTN), a history of myocardial infarction (MI) or stroke may have to be considered.
Prior MI or stroke may predict diuretic use for HTN management
01 Aug 2024
Nearly half of dementia cases preventable by tackling 14 risk factors
Nearly half of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors starting from childhood, including two new risk factors – high LDL-cholesterol (LDL-C) level and untreated vision loss – according to a report of the 2024 Lancet Commission on dementia.
Nearly half of dementia cases preventable by tackling 14 risk factors
01 Aug 2024
Hemp seed protein, hydrolysate may lower BP in hypertensive adults
Adults with hypertension may derive some benefits from consuming hemp protein, as well as its bioactive peptides, suggests a study.
